Panagora Asset Management’s Voyager Therapeutics VYGR Stock Holding History

Panagora Asset Management’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$809K	Buy	+231,077	New	+$876K	﹤0.01%	779
2021 Q2	–	Sell	-631	Closed	-$3K	–	2966
2021 Q1	$3K	Hold	631	–	–	﹤0.01%	2678
2020 Q4	$5K	Buy	+631	New	+$6.07K	﹤0.01%	2480
2020 Q2	–	Sell	-579	Closed	-$5K	–	2656
2020 Q1	$5K	Sell	579 -7,731	-93%	-$88.7K	﹤0.01%	2272
2019 Q4	$116K	Buy	8,310 +579	+7%	+$8.42K	﹤0.01%	1767
2019 Q3	$133K	Hold	7,731	–	–	﹤0.01%	1759
2019 Q2	$210K	Buy	+7,731	New	+$177K	﹤0.01%	1778

Other funds holding VYGR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Panagora Asset Management's VYGR Position: Q2 2026 in Review

Panagora Asset Management opened a new position in Voyager Therapeutics (VYGR) in Q2 2026: 231,077 shares worth $809K. The stake represents ﹤0.01% of the portfolio and ranks #779 among its holdings. This is a return to the name: Panagora Asset Management previously reported a position in VYGR as recently as Q1 2021.

Panagora Asset Management first reported a position in VYGR in Q2 2019 and has held it in 7 quarters since. 135 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

Panagora Asset Management held 231,077 shares of Voyager Therapeutics worth $809K as of Q2 2026.
Voyager Therapeutics was a new Panagora Asset Management position in Q2 2026.
Voyager Therapeutics made up ﹤0.01% of Panagora Asset Management's portfolio in Q2 2026, its #779 holding.
Panagora Asset Management first reported a position in Voyager Therapeutics in Q2 2019 and has held it in 7 quarters since.
135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.